UB Paderborn / Katalog / Suche / in CDI

Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality

International journal of radiation oncology, biology, physics, 2016-06, Vol.95 (2), p.772-781

2016

Link zum Volltext

Verfügbarkeit prüfen

Short-Course Treatment With Gefitinib Enhances Curative Potential of Radiation Therapy in a Mouse Model of Human Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-03, Vol.88 (4), p.947-954

2014

Link zum Volltext

Verfügbarkeit prüfen

Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (Review)

International journal of molecular medicine, 2009-11, Vol.24 (5), p.591-597

2009

Link zum Volltext

Verfügbarkeit prüfen

Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells

Oncotarget, 2014-07, Vol.5 (13), p.4765-4778

2014

Link zum Volltext

Verfügbarkeit prüfen

Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer

International journal of oncology, 2015-09, Vol.47 (3), p.849-856

2015

Link zum Volltext

Verfügbarkeit prüfen

Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture

Lung cancer (Amsterdam, Netherlands), 2015-11, Vol.90 (2), p.191-198

2015

Link zum Volltext

Verfügbarkeit prüfen

Bone morphogenetic protein‐10 (BMP‐10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer

Cancer science, 2010-10, Vol.101 (10), p.2137-2144

2010

Link zum Volltext

Verfügbarkeit prüfen

Growth and differentiation factor 9 (GDF-9) induces epithelial-mesenchymal transition in prostate cancer cells

Molecular and cellular biochemistry, 2011-03, Vol.349 (1-2), p.33-40

2011

Link zum Volltext

Verfügbarkeit prüfen

GDF-9 promotes the growth of prostate cancer cells by protecting them from apoptosis

Journal of cellular physiology, 2010-11, Vol.225 (2), p.529-536

2010

Link zum Volltext

Verfügbarkeit prüfen

Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway

Oncology reports, 2010-12, Vol.24 (6), p.1653-1659

2010

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer

Oncotarget, 2016-09, Vol.7 (38), p.60807-60822

2016

Link zum Volltext

Verfügbarkeit prüfen

Reduced Expression of BMPR-IB Correlates with Poor Prognosis and Increased Proliferation of Breast Cancer Cells

Cancer genomics & proteomics, 2009-03, Vol.6 (2), p.101-108

2009

Link zum Volltext

Verfügbarkeit prüfen

Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (Review)

International journal of molecular medicine, 2009-09, Vol.24 (5)

Ye

2009

Link zum Volltext

Verfügbarkeit prüfen

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant

Cell reports. Medicine, 2022-10, Vol.3 (10), p.100783-100783, Article 100783

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3785: Olaparib increases the effectiveness of radiation in hypoxic tumor cells in xenograft models of human non-small-cell lung cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3785-3785

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract C114: The role of LKB1 and TP53 mutation status in determining sensitivity of non-small cell lung cancer cells to the metabolic inhibitors; metformin, phenformin and 2-DG

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.C114-C114

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract B88: Mechanisms of resistance to the Hsp90 inhibitor ganetespib in triple negative breast cancer

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.B88-B88

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract B276: A live-cell apoptosis assay identifies novel combination approaches that selectively kill EGFR mutant NSCLC cells

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B276-B276

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract B91: Combined ATM and ATR kinase inhibition selectively kills p53-mutated non-small cell lung cancer (NSCLC) cells

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B91-B91

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5254: Cedarinib inhibits VEGF-stimulated proliferation in NSCLC cell lines

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5254-5254

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract A154: Preclinical investigation of gefitinib combined with radiation in EGFR -mutation positive non-small cell lung cancer

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A154-A154

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB120: Comprehensive biomarkers analysis to explain resistances to PD1-L1 ICIs: The precision immuno-oncology for advanced non-small cell lung cancer (PIONeeR) trial

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.LB120-LB120

2022

Link zum Volltext

Verfügbarkeit prüfen

Role of bone morphogenetic proteins and their signalling in human cancers

Bokobza, Sivan

2010

Link zum Volltext
ProQuest

Menü

Weitere Dienste

Einstellungen

Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality

Short-Course Treatment With Gefitinib Enhances Curative Potential of Radiation Therapy in a Mouse Model of Human Non-Small Cell Lung Cancer

Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (Review)

Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells

Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer

Acute vascular response to cediranib treatment in human non-small-cell lung cancer xenografts with different tumour stromal architecture

Bone morphogenetic protein‐10 (BMP‐10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer

Growth and differentiation factor 9 (GDF-9) induces epithelial-mesenchymal transition in prostate cancer cells

GDF-9 promotes the growth of prostate cancer cells by protecting them from apoptosis

Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway

Phenotypic consequences of somatic mutations in the ataxia-telangiectasia mutated gene in non-small cell lung cancer

Reduced Expression of BMPR-IB Correlates with Poor Prognosis and Increased Proliferation of Breast Cancer Cells

Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (Review)

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant

Abstract 3785: Olaparib increases the effectiveness of radiation in hypoxic tumor cells in xenograft models of human non-small-cell lung cancer

Abstract C114: The role of LKB1 and TP53 mutation status in determining sensitivity of non-small cell lung cancer cells to the metabolic inhibitors; metformin, phenformin and 2-DG

Abstract B88: Mechanisms of resistance to the Hsp90 inhibitor ganetespib in triple negative breast cancer

Abstract B276: A live-cell apoptosis assay identifies novel combination approaches that selectively kill EGFR mutant NSCLC cells

Abstract B91: Combined ATM and ATR kinase inhibition selectively kills p53-mutated non-small cell lung cancer (NSCLC) cells

Abstract 5254: Cedarinib inhibits VEGF-stimulated proliferation in NSCLC cell lines

Abstract A154: Preclinical investigation of gefitinib combined with radiation in EGFR -mutation positive non-small cell lung cancer

Abstract LB120: Comprehensive biomarkers analysis to explain resistances to PD1-L1 ICIs: The precision immuno-oncology for advanced non-small cell lung cancer (PIONeeR) trial

Role of bone morphogenetic proteins and their signalling in human cancers

Suchergebnisse filtern